Skip to content

Prematurity-Related Ventilatory Control: Role in Respiratory Outcomes

Prematurity-Related Ventilatory Control: Role in Respiratory Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03174301
Acronym
Pre-Vent
Enrollment
739
Registered
2017-06-02
Start date
2018-03-09
Completion date
2021-06-04
Last updated
2022-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant, Premature

Brief summary

The objective of this common multicenter protocol is to test the hypothesis that algorithmic tools using clinical Neonatal Intensive Care Unit (NICU) cardiorespiratory monitoring data can detect ventilatory control instability and predict chronic and acute respiratory consequences of ventilatory control instability and autonomic dysregulation.

Interventions

None listed

Sponsors

Case Western Reserve University
CollaboratorOTHER
Northwestern University
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
University of Miami
CollaboratorOTHER
Washington University School of Medicine
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Brown University
CollaboratorOTHER
University of Virginia
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Weeks
Healthy volunteers
No

Inclusion criteria

* Neonatal Intensive Care Unit patient on cardiorespiratory monitor which has been configured to collect data to store for this study * \< 29 wks Gestational Age * \< 1 wk Chronological

Exclusion criteria

* Unlikely to survive or decision not to pursue full care * Major congenital or chromosomal anomaly

Design outcomes

Primary

MeasureTime frameDescription
Clinical Outcome40 weeks post-menstrual age.Favorable: Either (1) an inpatient at 40 weeks post-menstrual age and not on oxygen, nor on other flow/pressure respiratory support, nor on inhaled/oral/IV respiratory medications, OR (2) discharged prior to 40 weeks post-menstrual age not on respiratory meds, oxygen, or other respiratory support. Unfavorable: Either (1) Deceased at 40 weeks , (2) inpatient on meds/O2/support at 40 weeks post-menstrual age, or (3) previously discharged prior to 40 weeks on meds/O2/support
Physiological Outcome36 weeks and 1 day to 37 weeks and 0 days, post-menstrual ageReported Value will be the percentile value of scores, as plotted on a standard curve of scores for peers. The score is calculated by aggregating the following measurements: 1. Periodic Breathing Percentage (%) 2. Number of Apnea events (#) 3. Number of Bradycardia events (#) 4. Number of Desaturation events (#) 5. Number of combined events (example Apnea with Bradycardia and Desaturation (#)

Secondary

MeasureTime frame
pulmonary hypertensionbefore 52 weeks post-menstrual age
time on respiratory support and medicationsbefore 52 weeks post-menstrual age
necrotizing enterocolitisbefore 52 weeks post-menstrual age
sepsisbefore 52 weeks post-menstrual age
chronic lung diseasebefore 52 weeks post-menstrual age

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026